Resource Library

Among the 47 million Americans living with cardiometabolic disorders, people of color are disproportionately affected, particularly Hispanic Americans.

How you can take action this year before obesity expenses completely fall off the rails? Learn more in this webinar.

Can your organization’s health outcomes be considered successful if they aren’t equitable? Learn more in this webinar.

Richard Frank, Chief Medical Officer at Vida Health, and Sara Izadi, Chief Clinical Officer at Capital Rx,  discuss effective GLP-1 utilization management strategies for diverse populations.

Dr. Fatima Cody Stanford, Associate Professor of Medicine at Harvard Medical School, and Dr. Richard Frank, Vida’s Chief Medical Officer, discuss implementing a virtual obesity center of excellence to meet this disease head-on.

Organizations are inundated with obesity solutions, and uncovering the actual clinical impact of an individual solution can be difficult. How can organizations know what to look for when evaluating solutions?

How do we best address the issue at its root and develop holistic solutions to tackle the broader aspects of well-being?

Some of the largest organizations in the US spend upwards of $16,000 per person per year on costs associated with GLP-1s. How much are you willing to spend on GLP-1s annually? Learn about how GLP-1 and other anti-obesity medications can be properly managed without costly lifetime prescriptions.

What role should medications play in treating obesity? In this webinar Obesity expert Dr. Fatima Cody and Vida’s Chief Medical Officer Dr. Richard Frank discuss.